Dental Patient Care America(DPAT)
$0.030.00 (0.00%)
DPAT
Dental Patient Care America financials statements
$0.03
At close:0.00 (0.00%)
Dental Patient Care America (DPAT) Ratios
1 Followers
Dental Patient Care America Ratios
DPAT's free cash flow for Q2 2026 was $202.15K. For the 2026 fiscal year, DPAT's free cash flow was decreased by $-5.51K and operating cash flow was $207.66K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 1.71 | 1.37 | 1.24 |
| Quick Ratio | 1.71 | 1.37 | 1.24 |
| Cash Ratio | 0.06 | 1.34 | 1.12 |
| Solvency Ratio | 0.41 | 0.15 | 0.01 |
| Operating Cash Flow Ratio | 0.53 | 0.09 | 0.49 |
| Short-Term Operating Cash Flow Coverage | 14.08 | 1.71 | 32.47 |
| Net Current Asset Value | $ 843.39K | $ 415.84K | $ 436.88K |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.05 | 0.10 | 0.01 |
| Debt-to-Equity Ratio | 0.12 | 0.33 | 0.06 |
| Debt-to-Capital Ratio | 0.10 | 0.25 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.12 | 3.39 | 5.08 |
| Debt Service Coverage Ratio | 2.87 | 3.11 | 0.44 |
| Interest Coverage Ratio | 45.95 | 144.76 | -14.37 |
| Debt to Market Cap | 0.14 | 0.22 | 0.06 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.00 |
| Net Debt to EBITDA | 0.33 | -6.98 | -155.13 |
| Profitability Margins | |||
| Gross Profit Margin | 99.83% | 99.93% | 99.95% |
| EBIT Margin | 6.83% | 10.71% | 0.34% |
| EBITDA Margin | 7.01% | 10.78% | 0.40% |
| Operating Profit Margin | 6.83% | 6.35% | -0.97% |
| Pretax Profit Margin | 21.87% | 10.66% | 0.28% |
| Net Profit Margin | 20.31% | 10.66% | 0.28% |
| Continuous Operations Profit Margin | 20.31% | 10.66% | 0.28% |
| Net Income Per EBT | 92.83% | 100.00% | 100.00% |
| EBT Per EBIT | 320.07% | 167.80% | -28.44% |
| Return on Assets (ROA) | 21.47% | 10.84% | 0.40% |
| Return on Equity (ROE) | 45.42% | 36.70% | 2.03% |
| Return on Capital Employed (ROCE) | 14.19% | 18.03% | -7.14% |
| Return on Invested Capital (ROIC) | 12.71% | 16.44% | -6.73% |
| Return on Tangible Assets | 21.47% | 10.84% | 0.40% |
| Earnings Yield | 160.56% | 68.08% | 1.98% |
| Efficiency Ratios | |||
| Receivables Turnover | 191.26 | 53.98 | 15.10 |
| Payables Turnover | 0.21 | 0.06 | 0.08 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 10.74 | 8.53 | 755.41 |
| Asset Turnover | 1.06 | 1.02 | 1.45 |
| Working Capital Turnover Ratio | 3.80 | 4.80 | 0.00 |
| Cash Conversion Cycle | -1716.75 | -5729.04 | -4599.09 |
| Days of Sales Outstanding | 1.91 | 6.76 | 24.17 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1718.66 | 5735.80 | 4623.26 |
| Operating Cycle | 1.91 | 6.76 | 24.17 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | 0.03 | 0.01 | 0.04 |
| Free Cash Flow Per Share | 0.03 | 0.00 | 0.04 |
| Dividend Paid and CapEx Coverage Ratio | 16.37 | 1.81 | 438299.00 |
| Capital Expenditure Coverage Ratio | 16.37 | 1.81 | 438299.00 |
| Operating Cash Flow Coverage Ratio | 4.74 | 0.61 | 32.47 |
| Operating Cash Flow to Sales Ratio | 0.25 | 0.06 | 0.27 |
| Free Cash Flow Yield | 182.52% | 16.71% | 193.43% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | 0.62 | 1.47 | 50.50 |
| Price-to-Sales (P/S) Ratio | 0.13 | 0.16 | 0.14 |
| Price-to-Book (P/B) Ratio | 0.28 | 0.54 | 1.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.55 | 5.99 | 0.52 |
| Price-to-Operating Cash Flow Ratio | 0.51 | 2.68 | 0.52 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | 2.14 | -5.52 | -119.93 |
| Enterprise Value | 428.05K | -1.43M | -1.54M |
| EV to EBITDA | 2.14 | -5.52 | -119.93 |
| EV to Sales | 0.15 | -0.60 | -0.48 |
| EV to Free Cash Flow | 0.65 | -22.75 | -1.76 |
| EV to Operating Cash Flow | 0.61 | -10.20 | -1.76 |
| Tangible Book Value Per Share | 0.05 | 0.03 | 0.02 |
| Shareholders’ Equity Per Share | 0.05 | 0.03 | 0.02 |
| Tax and Other Ratios | |||
| Effective Tax Rate | 0.07 | 0.00 | 0.00 |
| Revenue Per Share | 0.12 | 0.10 | 0.13 |
| Net Income Per Share | 0.02 | 0.01 | 0.00 |
| Tax Burden | 0.93 | 1.00 | 1.00 |
| Interest Burden | 3.20 | 1.00 | 0.80 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.93 | 0.94 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.21 | 0.55 | 97.68 |
Currency in USD
